BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7700614)

  • 1. Allergic contact dermatitis from tixocortol pivalate in a nasal spray masquerading as infectious complication of sinusitis.
    Bircher AJ; Hirsbrunner P; Tschopp K; Wildermuth V
    ORL J Otorhinolaryngol Relat Spec; 1995; 57(1):54-6. PubMed ID: 7700614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contact allergy to hydrocortisone and systemic contact dermatitis from prednisolone with tolerance of betamethasone.
    Isaksson M; Persson LM
    Am J Contact Dermat; 1998 Jun; 9(2):136-8. PubMed ID: 9601904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contact hypersensitivity to tixocortol pivalate.
    Lutz ME; el-Azhary RA; Gibson LE; Fransway AF
    J Am Acad Dermatol; 1998 May; 38(5 Pt 1):691-5. PubMed ID: 9591812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patch testing with corticosteroid mixes in Europe. A multicentre study of the EECDRG.
    Isaksson M; Andersen KE; Brandão FM; Bruynzeel DP; Bruze M; Camarasa JG; Diepgen T; Ducombs G; Frosch PJ; Goossens A; Lahti A; Menné T; Rycroft RJ; Seidenari S; Shaw S; Tosti A; Wahlberg J; White IR; Wilkinson JD
    Contact Dermatitis; 2000 Jan; 42(1):27-35. PubMed ID: 10644022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact hypersensitivity to hydrocortisone-free-alcohol in patients with allergic patch test reactions to tixocortol pivalate.
    Lauerma AI; Tarvainen K; Forström L; Reitamo S
    Contact Dermatitis; 1993 Jan; 28(1):10-4. PubMed ID: 8428438
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of contact allergy to corticosteroids in a Danish patient population.
    Svendsen SV; Bach RO; Mortz CG
    Contact Dermatitis; 2022 Sep; 87(3):273-279. PubMed ID: 35460519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical relevance of tixocortol pivalate-positive patch tests and questionable bioequivalence of different hydrocortisone preparations.
    Shaw DW; Maibach HI
    Contact Dermatitis; 2013 Jun; 68(6):369-75. PubMed ID: 23692037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tixocortol pivalate contact allergy in the GPMT: frequency and cross-reactivity.
    Frankild S; Lepoittevin JP; Kreilgaard B; Andersen KE
    Contact Dermatitis; 2001 Jan; 44(1):18-22. PubMed ID: 11156006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for corticosteroid contact sensitivity. Comparison of tixocortol pivalate, hydrocortisone-17-butyrate and hydrocortisone.
    Lauerma AI
    Contact Dermatitis; 1991 Feb; 24(2):123-30. PubMed ID: 1828209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patch testing to detect corticosteroid allergy: is it adequate?
    Seukeran DC; Wilkinson SM; Beck MH
    Contact Dermatitis; 1997 Mar; 36(3):127-30. PubMed ID: 9145260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patch testing for corticosteroid allergy with low and high concentrations of tixocortol pivalate and budesonide.
    Chowdhury MM; Statham BN; Sansom JE; Foulds IS; English JS; Podmore P; Bourke J; Orton D; Ormerod AD
    Contact Dermatitis; 2002 May; 46(5):311-2. PubMed ID: 12084094
    [No Abstract]   [Full Text] [Related]  

  • 12. Guinea pig maximization test assessment of hydrocortisone and tixocortol pivalate.
    Mirshahpanah P; Maibach HI
    Cutan Ocul Toxicol; 2007; 26(4):375-82. PubMed ID: 18058310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroid-induced contact dermatitis: a pragmatic approach.
    English JS
    Clin Exp Dermatol; 2000 Jun; 25(4):261-4. PubMed ID: 10971480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patch-testing with serial dilutions of tixocortol pivalate and potential cross-reactive substances.
    Isaksson M; Bruze M; Goossens A; Lepoittevin JP
    Acta Derm Venereol; 2000; 80(1):33-8. PubMed ID: 10721831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Probable active sensitization to tixocortol pivalate.
    Goldsmith PC; White IR; Rycroft RJ; McFadden JP
    Contact Dermatitis; 1995 Dec; 33(6):429. PubMed ID: 8706404
    [No Abstract]   [Full Text] [Related]  

  • 16. Corticosteroid contact hypersensitivity: what vehicle and concentration?
    Wilkinson SM; Beck MH
    Contact Dermatitis; 1996 May; 34(5):305-8. PubMed ID: 8807220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pattern of corticosteroid allergy in Thailand.
    Wattanakrai P; Temnithikul B; Pootongkam S
    Dermatitis; 2010; 21(4):203-6. PubMed ID: 20646671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Are the Spanish baseline series markers sufficient to detect contact allergy to corticosteroids in Spain? A GEIDAC prospective study.
    Mercader-García P; Pastor-Nieto MA; García-Doval I; Giménez-Arnau A; González-Pérez R; Fernández-Redondo V; Serra-Baldrich E; Cordoba-Guijarro S; Gatica-Ortega ME; Silvestre-Salvador JF;
    Contact Dermatitis; 2018 Jan; 78(1):76-82. PubMed ID: 28960334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short induction phase of contact allergy to tixocortol pivalate in a nasal spray.
    Bircher AJ
    Contact Dermatitis; 1990 Apr; 22(4):237-8. PubMed ID: 2140756
    [No Abstract]   [Full Text] [Related]  

  • 20. Delayed hypersensitivity reactions to corticosteroids applied to mucous membranes.
    Bircher AJ; Pelloni F; Langauer Messmer S; Müller D
    Br J Dermatol; 1996 Aug; 135(2):310-3. PubMed ID: 8881682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.